Tom Arne Thorsen
Director/Board Member at Hubro Therapeutics AS
Network origin in Tom Arne Thorsen first degree
Entity | Entity type | Industry | |
---|---|---|---|
Hubro Therapeutics AS
Hubro Therapeutics AS BiotechnologyHealth Technology Hubro Therapeutics AS develops and trades biomedical products and services. It offers a technology platform for cancer vaccines targeting stomach and colon cancer. The company was founded by Jon Amund Eriksen on November 20, 2018 and is headquartered in Oslo, Norway.
5
| Holding Company | Biotechnology | 5 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Tom Arne Thorsen via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Oslo Cancer Cluster NCE
Oslo Cancer Cluster NCE Miscellaneous Commercial ServicesCommercial Services Oslo Cancer Cluster NCE is an oncology research firm that specializes in developing cancer diagnostics and medicines. The private company is based in Oslo, Norway. | Miscellaneous Commercial Services | Chief Executive Officer Chairman | |
AstraZeneca AS | Corporate Officer/Principal | ||
Radiumhospitalets Forskningsstiftelse
Radiumhospitalets Forskningsstiftelse Financial ConglomeratesFinance Radiumhospitalets Forskningsstiftelse invests in companies from Nordic research institutions. It is a pre-seed investor and project developer focused on cancer. It strengthens cancer research at Rikshospitalet University Hospital, including The Norwegian Radium Hospital. It provides Oslo Cancer Cluster with the necessary infrastructure and management team, as well. The company was founded in 1986 and is headquartered in Lysaker, Norway. | Financial Conglomerates | Chief Executive Officer | |
Biomolex AS
Biomolex AS Medical SpecialtiesHealth Technology Biomolex AS develops and delivers imaging systems for digital autoradiography. It offers Biomolex 700, a digital imager for protein micro-array analysis, including kinase analyses, protein interaction assays, single istotope deoxyribonucleic acid array analyses, micro analyses; and tissue imaging applications, such as foreign genetic material delivery, tissue specific distributions, uptake of antibodies, and uptake of labeled bio-molecules. The company was founded in May 2001 and is headquartered in Oslo, Norway. | Medical Specialties | Director/Board Member | |
University of Oslo | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
University of Groningen | College/University | Doctorate Degree | |
Kepler Cheuvreux SA (Switzerland)
Kepler Cheuvreux SA (Switzerland) Investment Banks/BrokersFinance Kepler Cheuvreux SA (Switzerland) (Kepler Cheuvreux Switzerland) is the Swiss broker/dealer division of Kepler Cheuvreux SA in France. The firm was founded in 1999 and is headquartered in Zurich. Kepler Cheuvreux Switzerland provides execution services platform that supports Equities, Fixed Income, Derivatives, ETFs, and Convertible Bonds. | Investment Banks/Brokers | Analyst-Equity | |
Boehringer Ingelheim Norway KS | Chief Tech/Sci/R&D Officer | ||
Reykjavik University | College/University | Doctorate Degree | |
ULTIMOVACS ASA | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer | |
CIRCIO HOLDING ASA | Biotechnology | Chairman Chief Operating Officer | |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Oncoinvent AS develops antibody based therapeutic molecules for cancer treatment. It offers antigen-binding domains that develops coupling to nanoparticles and drug candidates. The firm provides antibodies (the OI-antibodies) with clinical relevant binding-specificity and also designs molecules and drug conjugates for treatment of specific cancer diseases. The company was founded by Tina Bjornlund Bonsdorff, ?yvind Sverre Bruland, Roy Hartvig Larsen, and Thora Johanna Jonasdottir in 2010 and is headquartered in Oslo, Norway. | Pharmaceuticals: Major | Director/Board Member | |
Cercare Medical A/S
Cercare Medical A/S Packaged SoftwareTechnology Services Cercare Medical ApS provides automated identification of viable tissue in acute stroke. It develops technology within medical image processing and image database analytics. The firm creates diagnostic software. The company was founded by Kim Mouridsen and Mikkel Bo Hansen in October 2013 and is headquartered in Aarhus, Denmark. | Packaged Software | Corporate Officer/Principal | |
Curida AS
Curida AS Pharmaceuticals: MajorHealth Technology Curida AS engages in the production of pharmaceutical products for other pharmaceutical companies, both in Norway and abroad. It manufactures and markets nasal and inhalation drug products. The company was founded in 1974 and is headquartered in Elverum, Norway. | Pharmaceuticals: Major | Director/Board Member | |
Canica Holding AG
Canica Holding AG Investment ManagersFinance Canica Holding AG is a privately owned Swiss investment company that focuses on active, long-term ownership in sectors covering branded consumer goods and services, financial investments, real estate, and retail. The company is based in Pfäffikon, Switzerland, and was founded in 2015. The company has core expertise in business development, retail, brand development, and finance. Canica creates value for its stakeholders through excellence and is passionate about its investments, employees, sustainability, and the community at large. Christer Kjos has been the CEO of the company since 2015. | Investment Managers | Director of Investments | |
Bristol-Myers Squibb Norway Ltd. | Chief Tech/Sci/R&D Officer | ||
Cytovation AS
Cytovation AS Miscellaneous Commercial ServicesCommercial Services Cytovation AS is a Norwegian clinical stage immune-oncology company that focuses on developing Cypep-1, a first-in-class immunotherapy that targets the cell membrane of tumor cells. The company is a spin-off from the University of Bergen and is headquartered in Bergen, Norway. Cypep-1 has a unique mechanism of action that eliminates cancer cells by forming pores in the plasma membrane, releasing antigens to the immune system, promoting an inflammatory microenvironment, and inducing a tumor-specific immune response by in situ vaccination. Cytovation develops treatments for solid tumors in oncology and rare diseases, building on over 15 years of cutting-edge research. The CEO is Lars Prestegarden, and the company was founded by Rolf Bjerkvig, Per Eystein, and Stein Christian Mohn. | Miscellaneous Commercial Services | Director/Board Member | |
EXACT THERAPEUTICS | Biotechnology | Director/Board Member | |
The Johns Hopkins University (Investment Management)
The Johns Hopkins University (Investment Management) Investment ManagersFinance The Johns Hopkins University (Investment Management) (JHU-IM) is the pension fund management arm of The Johns Hopkins University, a private research university headquartered in Baltimore, Maryland. JHU-IM invests the endowments for the university, Johns Hopkins Hospital, and other related endowed entities. | Investment Managers | Director of Investments | |
VITMED AS | Chief Executive Officer | ||
Nucligen AS | Director/Board Member | ||
Occi Holding AS
Occi Holding AS Real Estate DevelopmentFinance Occi Holding AS is a Norwegian company that leases real estate properties. The private company is based in Hamar, Norway. | Real Estate Development | Director/Board Member |
Statistics
International
Norway | 18 |
Switzerland | 4 |
Netherlands | 2 |
Iceland | 2 |
Denmark | 2 |
Sectoral
Health Technology | 8 |
Finance | 7 |
Consumer Services | 4 |
Commercial Services | 3 |
Technology Services | 2 |
Operational
Director/Board Member | 15 |
Chairman | 7 |
Chief Executive Officer | 5 |
Doctorate Degree | 4 |
Chief Tech/Sci/R&D Officer | 3 |
Most connected contacts
Insiders | |
---|---|
Jónas Einarsson | 12 |
Øyvind Kongstun Arnesen | 10 |
Aitana Peire | 9 |
Jon Amund Eriksen | 3 |
Kjeld-Håkon Nilsen | 1 |
- Stock Market
- Insiders
- Tom Arne Thorsen
- Company connections